Cargando…

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

INTRODUCTION: Alzheimer’s disease (AD) is the most prevalent form of dementia with symptoms of deteriorating cognitive functions and memory loss, partially as a result of a decrease in cholinergic neurotransmission. The disease is incurable and treatment with cholinesterase inhibitors (ChEIs) is sym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karami, Azadeh, Darreh-Shori, Taher, Schultzberg, Marianne, Eriksdotter, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426513/ https://www.ncbi.nlm.nih.gov/pubmed/34512307 http://dx.doi.org/10.3389/fnagi.2021.704583

Ejemplares similares

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
por: Eyjolfsdottir, Helga, et al.
Publicado: (2022)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
por: Mitra, Sumonto, et al.
Publicado: (2021)

Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase
por: Kumar, Amit, et al.
Publicado: (2018)

Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects
por: Teitsdottir, Unnur D., et al.
Publicado: (2022)

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
por: Lana, Erica, et al.
Publicado: (2019)

Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs
por: Kumar, Rajnish, et al.
Publicado: (2016)

Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer’s Disease Brain
por: Darreh-Shori, Taher, et al.
Publicado: (2018)

Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
por: Vijayaraghavan, Swetha, et al.
Publicado: (2013)

Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
por: Malmsten, Linn, et al.
Publicado: (2014)

Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
por: Sinclair, Lindsey Isla, et al.
Publicado: (2019)

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
por: Eyjolfsdottir, Helga, et al.
Publicado: (2016)

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
por: Teitsdottir, Unnur D., et al.
Publicado: (2020)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization
por: Kumar, Rajnish, et al.
Publicado: (2016)

Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App(NL−G−F) knock-in Alzheimer mice
por: Tambaro, Simone, et al.
Publicado: (2023)

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia
por: Liu, Qing, et al.
Publicado: (2017)

Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses
por: Ruan, Qingwei, et al.
Publicado: (2018)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
por: Kumar, Rajnish, et al.
Publicado: (2017)

Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment
por: Paul, Saswati, et al.
Publicado: (2015)

Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling
por: Baidya, Anurag TK, et al.
Publicado: (2022)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Subgingival microbiota in a population with and without cognitive dysfunction
por: Holmer, Jacob, et al.
Publicado: (2021)

Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
por: Leyhe, Thomas, et al.
Publicado: (2013)

Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities
por: Chang, Eric H., et al.
Publicado: (2019)

Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
por: Cotta Ramusino, Matteo, et al.
Publicado: (2021)

Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment
por: Musaeus, Christian Sandøe, et al.
Publicado: (2019)

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
por: Berezhnoy, Georgy, et al.
Publicado: (2023)

Cholinergic modulation of cognitive processing: insights drawn from computational models
por: Newman, Ehren L., et al.
Publicado: (2012)

Cognitive effects of thalamostriatal degeneration are ameliorated by normalizing striatal cholinergic activity
por: Becchi, Serena, et al.
Publicado: (2023)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
por: Guan, Jingjing, et al.
Publicado: (2020)

Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion
por: Turnbull, Marion T., et al.
Publicado: (2018)

Polypyrimidine tract binding protein knockdown reverses depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons
por: Zhou, Yiying, et al.
Publicado: (2023)

Impaired spatial learning and suppression of sharp wave ripples by cholinergic activation at the goal location
por: Jarzebowski, Przemyslaw, et al.
Publicado: (2021)

Bergapten Improves Scopolamine-Induced Memory Impairment in Mice via Cholinergic and Antioxidative Mechanisms
por: Kowalczyk, Joanna, et al.
Publicado: (2020)

Potential Role of OERP as Early Marker of Mild Cognitive Impairment
por: Invitto, Sara, et al.
Publicado: (2018)

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018)

Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis
por: Kaltsatou, Antonia, et al.
Publicado: (2015)

Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons
por: Latina, Valentina, et al.
Publicado: (2017)

Editorial: Brain cholinergic mechanisms
por: Vijayaraghavan, Sukumar, et al.
Publicado: (2015)

Cerebral Blood Flow Alterations as Assessed by 3D ASL in Cognitive Impairment in Patients with Subcortical Vascular Cognitive Impairment: A Marker for Disease Severity
por: Sun, Yawen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_16pg9km8r4lj1u2v9o5idphtvu